Authors: MEKKI QA PISCITELLI D FITZSIMMONS WE ARO R

Citation: Qa. Mekki et al., PHARMACOKINETICS OF TACROLIMUS (FK506) IN BONE-MARROW TRANSPLANT PATIENTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 149-149

Authors: DEVINE SM GELLER RB HOLLAND HK MORRIS LE WINTON EF HEFFNER LT HILLYER CD RODEY GE DIX SP OTOOLE K ROUTENBERG K VOGLER WR MAUER D ARO R FITZSIMMONS WE WINGARD JR

Citation: Sm. Devine et al., FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER MATCHED UNRELATED DONOR (MUD) MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000341-10000341

Authors: FAY JW COLLINS RH PINEIRO LA NEMUNAITIS JJ ARO R FITZSIMMONS W

Citation: Jw. Fay et al., FK506 TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW TRANSPLANTATION (AMT) USING UNRELATED MARROW DONORS (UMD)-A PHASE-II STUDY, Blood, 82(10), 1993, pp. 10000420-10000420